Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CALC

CalciMedica Inc

Dec 13 • 03:32PM ET

2.77

Dollar change -0.02
Percentage change -0.90	%

Healthcare • Biotechnology • USA • NASD

Peers: PIRS LCTX APLT COGT GALT DTIL SYBX BIVI JAGX LVTX

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.57	Insider Own	46.42%	Shs Outstand	10.76M	Perf Week	-3.32%
Market Cap	37.27M	Forward P/E	-	EPS next Y	-0.93	Insider Trans	7.87%	Shs Float	7.22M	Perf Month	-18.68%
Income	-13.59M	PEG	-	EPS next Q	-0.44	Inst Own	15.30%	Short Float	0.63%	Perf Quarter	-32.06%
Sales	0.00M	P/S	-	EPS this Y	80.16%	Inst Trans	-18.59%	Short Ratio	0.76	Perf Half Y	-43.34%
Book/sh	0.84	P/B	3.30	EPS next Y	38.82%	ROA	-84.77%	Short Interest	0.05M	Perf Year	-17.46%
Cash/sh	1.08	P/C	2.55	EPS next 5Y	-	ROE	-128.26%	52W Range	2.05 - 8.38	Perf YTD	-3.32%
Dividend Est.	-	P/FCF	-	EPS past 5Y	19.56%	ROI	-150.48%	52W High	-67.00%	Beta	1.23
Dividend TTM	-	Quick Ratio	4.15	Sales past 5Y	0.00%	Gross Margin	-	52W Low	34.88%	ATR (14)	0.26
Dividend Ex-Date	-	Current Ratio	4.15	EPS Y/Y TTM	94.80%	Oper. Margin	-	RSI (14)	31.22	Volatility	15.88% 7.78%
Employees	14	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	15.75
Option/Short	No / Yes	LT Debt/Eq	0.00	EPS Q/Q	38.10%	Payout	-	Rel Volume	0.63	Prev Close	2.79
Sales Surprise	-	EPS Surprise	11.11%	Sales Q/Q	-	Earnings	Nov 13 BMO	Avg Volume	59.07K	Price	2.77
SMA20	-13.08%	SMA50	-22.90%	SMA200	-36.70%	Trades		Volume	34,874	Change	-0.90%

Nov-21-24 08:00AM	CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference (PR Newswire)
Nov-20-24 04:05PM	CalciMedica Announces Presentations at Upcoming Medical Meetings (PR Newswire)
Nov-13-24 07:00AM	CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
Nov-07-24 07:00AM	CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer (PR Newswire)
Oct-30-24 10:11PM	CalciMedica Announces Pricing of Public Offering of Common Stock (PR Newswire) +22.14% -22.92%
04:50PM	Loading…
04:50PM	CalciMedica Announces Proposed Public Offering of Common Stock (PR Newswire)
07:00AM	CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting (PR Newswire)
Oct-28-24 04:05PM	CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) (PR Newswire)
Oct-16-24 08:00AM	CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting (PR Newswire)
Sep-03-24 08:00AM	CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference (PR Newswire) +7.67%
Aug-12-24 04:10PM	CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
Jul-09-24 07:30AM	CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora in Severe Acute Kidney Injury (AKI) (PR Newswire)
Jul-08-24 08:00AM	CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences (PR Newswire)
Jul-01-24 08:00AM	CalciMedica Set to Join Russell Microcap Index (PR Newswire) +7.32%
Jun-27-24 08:00AM	CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) (PR Newswire) -32.40%
07:06AM	Loading…
07:06AM	CalciMedica's calcium channel inhibitor helps subgroup of pancreatitis patients eat solids sooner (FierceBiotech.com)
Jun-26-24 04:05PM	CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) (PR Newswire) -10.04%
May-28-24 07:53AM	CALC Stock Earnings: CalciMedica Beats EPS for Q1 2024 (InvestorPlace)
May-21-24 09:48AM	3 Massively Undervalued 10-Bagger Stocks to Buy (InvestorPlace)
May-13-24 04:05PM	CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates (PR Newswire) -7.14% +6.73%
May-07-24 08:00AM	CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024 (PR Newswire)
Apr-24-24 08:00AM	CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (PR Newswire) +19.61%
Apr-10-24 03:30PM	Insiders are Piling into These 10 Healthcare Stocks in 2024 (Insider Monkey)
Mar-28-24 11:53AM	CALC Stock Earnings: CalciMedica Reported Results for Q4 2023 (InvestorPlace)
07:00AM	CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
Mar-13-24 08:00AM	CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference (PR Newswire)
Feb-28-24 06:57PM	CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference (PR Newswire)
Feb-13-24 08:00AM	CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora for the Treatment of Severe Acute Kidney Injury (PR Newswire) -8.21%
Feb-07-24 04:05PM	CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (PR Newswire) +6.92% -9.99%
Jan-22-24 08:00AM	CalciMedica Announces Private Placement of up to Approximately $55 Million (PR Newswire) +7.09%
07:30AM	Loading…
Dec-11-23 07:30AM	CalciMedica Collaborator St. Jude Children's Research Hospital Presents Data from Initial Cohort of CRSPA Study at 65th Annual ASH Meeting & Exposition (PR Newswire) -13.88%
Nov-09-23 07:00AM	CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates (PR Newswire) -12.74%
Nov-02-23 09:15AM	CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition (PR Newswire) +10.23%
Sep-06-23 07:30AM	CalciMedica Announces Upcoming Presentations and Events in September (PR Newswire) +5.18%
Aug-31-23 07:30AM	CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023 (PR Newswire)
Aug-11-23 07:01AM	Daily Vickers Top Insider Picks for 08/11/2023 (Argus Research)
Aug-10-23 04:05PM	CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates (GlobeNewswire)
06:24AM	Daily Vickers Top Insider Picks for 08/10/2023 (Argus Research)
Aug-09-23 07:30AM	CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora in Acute Pancreatitis (AP) (GlobeNewswire) +6.06%
06:26AM	Daily Vickers Top Insider Picks for 08/09/2023 (Argus Research)
Aug-08-23 06:28AM	Daily Vickers Top Insider Picks for 08/08/2023 (Argus Research)
Aug-07-23 06:35AM	Daily Vickers Top Insider Picks for 08/07/2023 (Argus Research)
Aug-04-23 07:14AM	Daily Vickers Top Insider Picks for 08/04/2023 (Argus Research)
Aug-03-23 07:15AM	Daily Vickers Top Insider Picks for 08/03/2023 (Argus Research)
Aug-02-23 07:52AM	Daily Vickers Top Insider Picks for 08/02/2023 (Argus Research)
Aug-01-23 06:51AM	Daily Vickers Top Insider Picks for 08/01/2023 (Argus Research) -6.29%
Jul-31-23 06:44AM	Daily Vickers Top Insider Picks for 07/31/2023 (Argus Research)
Jul-28-23 07:58AM	Daily Vickers Top Insider Picks for 07/28/2023 (Argus Research)
Jul-27-23 07:10AM	Daily Vickers Top Insider Picks for 07/27/2023 (Argus Research)
Jul-26-23 01:12PM	Daily Vickers Top Insider Picks for 07/26/2023 (Argus Research)
Jul-25-23 07:16AM	Daily Vickers Top Insider Picks for 07/25/2023 (Argus Research) -6.11%
Jul-24-23 07:12AM	Daily Vickers Top Insider Picks for 07/24/2023 (Argus Research)
Jul-21-23 07:23AM	Daily Vickers Top Insider Picks for 07/21/2023 (Argus Research)
Jul-20-23 06:55AM	Daily Vickers Top Insider Picks for 07/20/2023 (Argus Research)
Jul-19-23 07:10AM	Daily Vickers Top Insider Picks for 07/19/2023 (Argus Research)
Jul-18-23 06:53AM	Daily Vickers Top Insider Picks for 07/18/2023 (Argus Research) -5.56%
Jul-17-23 07:10AM	Daily Vickers Top Insider Picks for 07/17/2023 (Argus Research) +5.16%
Jul-14-23 06:50AM	Daily Vickers Top Insider Picks for 07/14/2023 (Argus Research)
Jul-13-23 07:02AM	Daily Vickers Top Insider Picks for 07/13/2023 (Argus Research)
Jul-12-23 07:22AM	Daily Vickers Top Insider Picks for 07/12/2023 (Argus Research) +7.08%
Jul-11-23 06:08AM	Daily Vickers Top Insider Picks for 07/11/2023 (Argus Research)
Jul-10-23 06:56AM	Daily Vickers Top Insider Picks for 07/10/2023 (Argus Research)
Jul-05-23 06:46AM	Daily Vickers Top Insider Picks for 07/05/2023 (Argus Research) +13.07%
Jul-03-23 06:50AM	Daily Vickers Top Insider Picks for 07/03/2023 (Argus Research)
Jun-30-23 06:52AM	Daily Vickers Top Insider Picks for 06/30/2023 (Argus Research) -17.32%
Jun-29-23 06:49AM	Daily Vickers Top Insider Picks for 06/29/2023 (Argus Research) +11.75%
Jun-28-23 06:58AM	Daily Vickers Top Insider Picks for 06/28/2023 (Argus Research)
Jun-27-23 06:46AM	Daily Vickers Top Insider Picks for 06/27/2023 (Argus Research) +28.00%
Jun-26-23 06:41AM	Daily Vickers Top Insider Picks for 06/26/2023 (Argus Research)
Jun-23-23 09:24AM	Daily Vickers Top Insider Picks for 06/23/2023 (Argus Research) -6.76%
Jun-12-23 07:30AM	CalciMedica Announces Relisting on Nasdaq (GlobeNewswire)
Jun-06-23 07:30AM	CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP) (GlobeNewswire) +16.85%
May-23-23 07:30AM	CalciMedica Expands Executive Team with New Appointments (GlobeNewswire) +9.49%
May-15-23 08:55AM	CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates (GlobeNewswire)
Mar-29-23 07:53PM	Charts Point to Higher Highs, Says Oppenheimer. Heres a Stock With Over 100% Upside Potential (TipRanks) -8.76% -29.60%

CalciMedica, Inc. operates as a biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate Auxora helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MIDDLETON FRED A	Director	Dec 06 '24	Buy	2.65	4,800	12,720	36,514	Dec 06 07:12 PM
Sanderling Venture Partners VI	10% Owner	Nov 01 '24	Buy	3.75	86,867	325,751	814,300	Nov 05 03:08 PM
Sanderling Venture Partners VI	10% Owner	Nov 01 '24	Buy	3.75	877	3,289	22,479	Nov 05 03:08 PM
MIDDLETON FRED A	Director	Nov 01 '24	Buy	3.75	87,744	329,040	814,300	Nov 05 03:04 PM
MIDDLETON FRED A	Director	Nov 01 '24	Buy	3.75	20,000	75,000	31,714	Nov 05 03:04 PM
Leheny A. Rachel	CHIEF EXECUTIVE OFFICER	Nov 01 '24	Buy	3.75	20,000	75,000	130,926	Nov 01 01:25 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Nov 01 '24	Buy	3.75	53,333	199,999	164,706	Nov 01 01:24 PM
WILSON ROBERT N	Director	Nov 01 '24	Buy	3.75	53,333	199,999	417,529	Nov 01 01:22 PM
Dunn Michael J.	President and COO	Sep 09 '24	Option Exercise	1.39	11,761	16,348	11,761	Sep 11 05:00 PM
Leheny A. Rachel	CHIEF EXECUTIVE OFFICER	Aug 27 '24	Buy	4.19	1,000	4,190	110,926	Aug 27 07:44 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Aug 23 '24	Buy	3.57	5,000	17,867	46,894	Aug 26 06:00 PM
WILSON ROBERT N	Director	Aug 23 '24	Buy	3.72	54,000	200,826	364,196	Aug 26 05:57 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Aug 21 '24	Buy	4.04	5,000	20,200	44,894	Aug 22 06:02 PM
WILSON ROBERT N	Director	Jun 28 '24	Buy	3.52	51,278	180,499	310,196	Jul 02 04:50 PM
WILSON ROBERT N	Director	Jun 27 '24	Buy	3.23	8,443	27,305	258,918	Jul 01 03:12 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Jun 27 '24	Buy	3.22	5,000	16,100	10,223	Jun 28 06:52 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Apr 02 '24	Buy	3.90	3,254	12,691	39,894	Apr 02 08:33 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Apr 01 '24	Buy	3.90	746	2,909	36,640	Apr 02 08:33 PM
MIDDLETON FRED A	Director	Jan 23 '24	Buy	3.70	679,384	2,515,080	946,744	Jan 25 08:00 PM
Sanderling Venture Partners VI	10% Owner	Jan 23 '24	Buy	3.70	436,028	1,614,176	727,433	Jan 25 08:00 PM
Sanderling Venture Partners VI	10% Owner	Jan 23 '24	Buy	3.70	243,356	900,904	946,744	Jan 25 08:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CALC

CalciMedica Inc

Upgrade your FINVIZ experience